
Javier Pinilla-Ibarz
Professor, Moffitt Cancer Center · University of South Florida Morsani College of Medicine
Credentials: · · · ·
History
- 1993–1994
Hematology
- 1990–1993
Internal Medicine
- 1986–1990
Doctor of Medicine
Research
A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias
New England Journal of Medicine · 2013 · 890 citations
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
New England Journal of Medicine · 2019 · 715 citations
Journal of Clinical Oncology · 2021 · 573 citations

30 papers

25 papers
- BS
20 papers · 1 as a fellow

19 papers
- RK
19 papers
- FL
18 papers
- KS
17 papers · 5 as a fellow

16 papers
Clinical trials
- 2023–2024
Principal investigator · Completed · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
- 2019–2026
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
Principal investigator · Active not recruiting · Phase 2
H. Lee Moffitt Cancer Center and Research Institute
- 2009–2013
Principal investigator · Completed · Phase 1
Deciphera Pharmaceuticals, LLC
- 2023–2027
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Site PI · Recruiting · Phase 1
Carna Biosciences, Inc.
